Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer — mSILSC  

Colorectal Cancer Clinical Trial

Official title: Multi-center Prospective Randomized Controlled Study of the Single-incision Laparoscopic Surgery Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Status Withdrawn

Clinical Trial Summary

This study is designed to evaluate the short-term and long-term results after single incision laparoscopic surgery for colorectal cancer（SILSC） compared with conventional laparoscopic surgery for colorectal cancer（CLSC）.

Clinical Trial Description

In order to improve cosmetic effect and reduce postoperative pain, single-incision laparoscopic surgery (SILS) is attracting increasing attention. SILS is considered to be the next major advance in the progress of minimally invasive surgical approaches to colorectal disease that is more feasible in generalized use. In most previous studies, SILS for colorectal cancer was feasible and short-term safe compared to conventional laparoscopic surgery (CLS) . However, there is still controversy over its potential better cosmetic effect and less postoperative pain. Moreover, the long-term oncologic outcomes are still inconclusive as only a few studies showed long-term survival data. Up to now, most studies were limited to their retrospective nature and small samples. So more studies, especially large-scale, randomized controlled trials are needed to establish the best indications for SILS for colorectal cancer. ;

Related Conditions & MeSH terms

• Colon Cancer
• Colon Disease
• Colonic Diseases
• Colonic Neoplasms
• Colorectal Cancer
• Colorectal Neoplasms
• Neoplasms
• Rectal Cancer
• Rectal Diseases
• Rectal Neoplasms

• NCT number: NCT03633539
• Study type: Interventional
• Source: Ruijin Hospital
• Status: Withdrawn
• Phase: N/A
• Start date: August 2020
• Completion date: December 2025